Literature DB >> 2984810

Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection.

T Paulin, O Ringdén, B Lönnqvist.   

Abstract

The following findings were noted among 45 bone marrow transplant recipients. The patients without cytomegalovirus (CMV) infection or chronic graft-versus-host disease (GVHD) showed normal lymphocyte stimulation in vitro by concanavalin A (Con A) more than 3 months after transplantation, and normal stimulation by phytohemagglutinin (PHA), anti-beta 2-microglobulin (A-beta 2m) and protein A (SpA) after 6 months. In contrast, the patients who had CMV infection without chronic GVHD had Con A and SpA responses within the normal range after 12 months and reduced lymphocyte responses to PHA and A-beta 2m more than 12 months after transplantation. The patients with chronic GVHD had reduced responses to all of these four mitogens after more than 12 months. In comparison with other patients those who later developed chronic GVHD showed an increased mixed lymphocyte culture stimulation during the first 3 months that decreased between 6-12 months. Patients with chronic GVHD still had reduced IgA levels at 12 months after transplantation. Patients with CMV infection, but without chronic GVHD, had higher percentages of lymphocytes with surface membrane Ig than healthy controls during the first 3 months after transplantation. The data suggest that CMV infection, regardless of chronic GVHD, delays immunologic recovery after marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984810     DOI: 10.1097/00007890-198504000-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation.

Authors:  H Kook; F Goldman; R Giller; N Goeken; C Peters; M Comito; S Rumelhart; M Holida; N Lee; M Trigg
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

2.  Designed transfer of specific immune responses with bone marrow transplantation.

Authors:  A Saxon; R Mitsuyasu; R Stevens; R E Champlin; H Kimata; R P Gale
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

Review 3.  Immune reconstitution following bone marrow transplantation.

Authors:  U N Verma; A Mazumder
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

Review 4.  Cytomegaloviral virus infection in bone marrow transplantation recipients: strategies for prevention and treatment.

Authors:  H K Holland; R Saral
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

Review 5.  Bone marrow transplantation using unrelated donors for haematological malignancies.

Authors:  O Ringdén
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

6.  Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients.

Authors:  H K Müller-Hermelink; G E Sale; B Borisch; R Storb
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

7.  Enhancive and suppressive effects of cytomegalovirus on human lymphocyte responses in vitro.

Authors:  B Wahren; P Ljungman; T Paulin; O Ringdén
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

8.  Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma.

Authors:  F W Busch; W Mutter; U H Koszinowski; M J Reddehase
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

Review 9.  Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma.

Authors:  M J Reddehase; L Dreher-Stumpp; P Angele; M Balthesen; M Susa
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 10.  Correlation of pretransplant viral serology and complications of bone marrow transplantation.

Authors:  O Ringdén
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.